Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes

QR Code

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes

Ana Catarina Pedrosa,1 Adriana Reis-Silva,2 João Pinheiro-Costa,1,3 João Beato,1 Paulo Freitas-da-Costa,1,3 Manuel S Falcão,1,2 Fernando Falcão-Reis,1,2 Ângela Carneiro1,2 1Department of Ophthalmology, Hospital de São João,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Pedrosa AC, Reis-Silva A, Pinheiro-Costa J, Beato J, Freitas-da-Costa P, Falcão MS, Falcão-Reis F, Carneiro A
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	Age-related macular degeneration choroidal neovascularization vascular endothelial growth factor visual acuity Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/4f3e16e908ce445b96d51d8719abdbb8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
par: Balaratnasingam C, et autres
Publié: (2015)

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
par: Cheema MR, et autres
Publié: (2021)

Management of neovascular age-related macular degeneration: Taiwan expert consensus
par: Ling Yeung, et autres
Publié: (2021)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
par: Yannuzzi NA, et autres
Publié: (2019)

Quantitative Comparison of the Vascular Structure of Macular Neovascularizations Between Swept-Source and Spectral-Domain Optical Coherence Tomography Angiography
par: Faatz H, et autres
Publié: (2020)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
par: Yan Lu, et autres
Publié: (2021)

Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021)

Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration
par: Almeida DRP, et autres
Publié: (2021)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
par: Khanani AM, et autres
Publié: (2019)

Comparison of choroidal neovascularization secondary to white dot syndromes and age-related macular degeneration by using optical coherence tomography angiography
par: Wang JC, et autres
Publié: (2018)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
par: Bhoomibunchoo C, et autres
Publié: (2017)

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
par: I-Chia Liang, et autres
Publié: (2021)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
par: Ryu G, et autres
Publié: (2021)

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
par: Hirakata T, et autres
Publié: (2016)

To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration
par: Furashova O, et autres
Publié: (2020)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
par: Hykin P, et autres
Publié: (2016)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
par: Patel PJ, et autres
Publié: (2017)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome
par: Chung WH, et autres
Publié: (2016)

Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
par: Hector SM, et autres
Publié: (2017)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021)

Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration
par: Adrean SD, et autres
Publié: (2020)

Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
par: Phan LT, et autres
Publié: (2021)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
par: Bhagat D, et autres
Publié: (2020)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
par: Sakamoto S, et autres
Publié: (2018)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
par: Kabanarou SA, et autres
Publié: (2017)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
par: Azuma K, et autres
Publié: (2018)

Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study
par: Leys AM, et autres
Publié: (2020)

Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
par: Andrea Montesel, et autres
Publié: (2021)

Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy
par: A. V. Grigorieva, et autres
Publié: (2021)

Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
par: Russo A, et autres
Publié: (2018)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
par: Maria Cristina Savastano, et autres
Publié: (2021)

Pachychoroid neovasculopathy in extramacular choroidal neovascularization
par: Gupta MP, et autres
Publié: (2016)

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2017)

Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
par: Miyamoto N, et autres
Publié: (2017)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
par: Garweg JG
Publié: (2019)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
par: Jia-Kang Wang, et autres
Publié: (2018)

Spotlight on reticular pseudodrusen
par: Rabiolo A, et autres
Publié: (2017)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
par: Jing Wang, et autres
Publié: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
par: Tan CS, et autres
Publié: (2017)